Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
11.00
-0.05 (-0.45%)
At close: Feb 11, 2026
TPEX:4186 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 113.6 | 106.32 | 182.14 | 158.56 | 159.7 | 236.89 |
Cash & Short-Term Investments | 113.6 | 106.32 | 182.14 | 158.56 | 159.7 | 236.89 |
Cash Growth | -17.98% | -41.62% | 14.87% | -0.71% | -32.59% | 122.95% |
Accounts Receivable | 91.57 | 97.56 | 51.84 | 62.43 | 67.29 | 52.83 |
Other Receivables | - | - | - | 0.25 | 0.13 | 0.96 |
Receivables | 91.57 | 97.56 | 51.84 | 62.68 | 67.43 | 53.79 |
Inventory | 21.45 | 19.16 | 21.17 | 23.42 | 24.11 | 25.01 |
Prepaid Expenses | - | - | 3 | - | - | 31.11 |
Other Current Assets | 10.88 | 5.4 | 1.16 | 15.48 | 16.42 | 0.55 |
Total Current Assets | 237.5 | 228.45 | 259.3 | 260.13 | 267.66 | 347.35 |
Property, Plant & Equipment | 231.1 | 234.03 | 246.27 | 255.02 | 256.79 | 261.3 |
Long-Term Investments | 85.01 | 78.23 | 93.9 | 72.94 | 67.75 | 52.49 |
Other Intangible Assets | 0.19 | 0.2 | 0.22 | 3.53 | 10.14 | 24.07 |
Long-Term Deferred Tax Assets | 9.88 | 9.88 | 9.81 | 8.82 | 8.73 | 13.07 |
Other Long-Term Assets | 128.66 | 125.65 | 139.08 | 106.34 | 102.67 | 125.17 |
Total Assets | 692.33 | 676.42 | 748.57 | 706.77 | 713.74 | 823.45 |
Accounts Payable | 8.9 | 8.48 | 16.65 | 14.55 | 11.55 | 14.44 |
Accrued Expenses | 0.16 | 31.94 | - | - | - | - |
Short-Term Debt | 180 | 140 | 180 | 130.95 | 107.86 | 116.91 |
Current Portion of Long-Term Debt | 17.76 | 24.54 | 36.52 | 35.71 | 20.92 | 13.75 |
Current Portion of Leases | 4.37 | 4.38 | 3.83 | 4.65 | 4.4 | 8.78 |
Current Unearned Revenue | 23.33 | 26.86 | 26.77 | 26.06 | 60.98 | 15.7 |
Other Current Liabilities | 30.27 | 2.69 | 53.05 | 31.15 | 39.36 | 46.37 |
Total Current Liabilities | 264.78 | 238.88 | 316.82 | 243.07 | 245.08 | 215.95 |
Long-Term Debt | 49.96 | 58.65 | 83.18 | 103.27 | 108.08 | 115.29 |
Long-Term Leases | 3.04 | 2.08 | 3.71 | 5.12 | 7.7 | 11.81 |
Long-Term Unearned Revenue | 120.27 | 118.54 | 109.08 | 109.07 | 109.63 | 117.22 |
Pension & Post-Retirement Benefits | - | - | - | - | 0.79 | 2.42 |
Long-Term Deferred Tax Liabilities | 0.85 | 0.85 | 0.97 | 0.71 | - | - |
Other Long-Term Liabilities | 0.87 | 0.98 | 0.89 | 0.89 | 1.01 | 1.87 |
Total Liabilities | 439.78 | 419.98 | 514.65 | 462.13 | 472.29 | 464.55 |
Common Stock | 900 | 900 | 900 | 900 | 900 | 900 |
Additional Paid-In Capital | - | - | - | - | 0.05 | 150 |
Retained Earnings | -646.4 | -642.51 | -665.72 | -654.95 | -658.6 | -691.1 |
Comprehensive Income & Other | -1.05 | -1.05 | -0.36 | -0.4 | - | - |
Shareholders' Equity | 252.55 | 256.44 | 233.92 | 244.64 | 241.45 | 358.9 |
Total Liabilities & Equity | 692.33 | 676.42 | 748.57 | 706.77 | 713.74 | 823.45 |
Total Debt | 255.13 | 229.64 | 307.24 | 279.7 | 248.97 | 266.53 |
Net Cash (Debt) | -141.52 | -123.32 | -125.11 | -121.15 | -89.27 | -29.64 |
Net Cash Per Share | -1.57 | -1.37 | -1.39 | -1.35 | -0.99 | -0.37 |
Filing Date Shares Outstanding | 90 | 90 | 90 | 90 | 90 | 90 |
Total Common Shares Outstanding | 90 | 90 | 90 | 90 | 90 | 90 |
Working Capital | -27.29 | -10.44 | -57.52 | 17.07 | 22.58 | 131.4 |
Book Value Per Share | 2.81 | 2.85 | 2.60 | 2.72 | 2.68 | 3.99 |
Tangible Book Value | 252.37 | 256.25 | 233.7 | 241.11 | 231.31 | 334.83 |
Tangible Book Value Per Share | 2.80 | 2.85 | 2.60 | 2.68 | 2.57 | 3.72 |
Land | 127.13 | 127.13 | 127.13 | 127.13 | 118.51 | 118.51 |
Buildings | 81.12 | 81.12 | 81.12 | 81.12 | 77.61 | 77.61 |
Machinery | 230.45 | 228.15 | 226.64 | 219.34 | 217.25 | 196.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.